Islet cell tumors of the pancreas - The medical oncologist's perspective

被引:105
作者
Brentjens, R [1 ]
Saltz, L [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Gastrointestinal Oncol Serv, New York, NY 10021 USA
关键词
D O I
10.1016/S0039-6109(05)70141-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Islet cell carcinomas are rare neuroendocrine tumors that arise from the Islets of Langerhans in the pancreas. Up to half of these tumors secrete one or more biologically active peptides. The only known cure is surgical resection. Patients with metastatic or unresectable disease can be palliated with mechanical ablative techniques such as hepatic arterial mobilization, radiation therapy palliative surgery, or chemotherapy. Current chemotherapies have only modest efficacy, and therefore patients should be encouraged to enroll in clinical trials testing newer antineoplastic agents to treatment modalities.
引用
收藏
页码:527 / +
页数:17
相关论文
共 102 条
[1]
ALTIMARI AF, 1987, SURGERY, V102, P1009
[2]
Results of liver transplantation for gastroenteropancreatic tumor metastases [J].
Anthuber, M ;
Jauch, KW ;
Briegel, J ;
Groh, J ;
Schildberg, FW .
WORLD JOURNAL OF SURGERY, 1996, 20 (01) :73-76
[3]
Evaluation of preoperative and intraoperative arterial stimulation and venous sampling for diagnosis and surgical resection of insulinoma [J].
Aoki, T ;
Sakon, M ;
Ohzato, H ;
Kishimoto, S ;
Oshima, S ;
Yamada, T ;
Higaki, N ;
Nakamori, S ;
Gotoh, M ;
Ishikawa, O ;
Ohigashi, H ;
Imaoka, S ;
Hasuike, Y ;
Shibata, K ;
Monden, M .
SURGERY, 1999, 126 (05) :968-973
[4]
SOMATOSTATIN ANALOG SANDOSTATIN AND INHIBITION OF TUMOR-GROWTH IN PATIENTS WITH METASTATIC ENDOCRINE GASTROENTEROPANCREATIC TUMORS [J].
ARNOLD, R ;
NEUHAUS, C ;
BENNING, R ;
SCHWERK, WB ;
TRAUTMANN, ME ;
JOSEPH, K ;
BRUNS, C .
WORLD JOURNAL OF SURGERY, 1993, 17 (04) :511-519
[5]
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours [J].
Arnold, R ;
Trautmann, ME ;
Creutzfeldt, W ;
Benning, R ;
Benning, M ;
Neuhaus, C ;
Jurgensen, R ;
Stein, K ;
Schafer, H ;
Bruns, C ;
Dennler, HJ .
GUT, 1996, 38 (03) :430-438
[6]
OCTREOTIDE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN CONDITIONS ASSOCIATED WITH EXCESSIVE PEPTIDE SECRETION [J].
BATTERSHILL, PE ;
CLISSOLD, SP .
DRUGS, 1989, 38 (05) :658-702
[7]
Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema [J].
Bewley, AP ;
Ross, JS ;
Bunker, CB ;
Staughton, RCD .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (06) :1101-1104
[8]
ISLET-CELL TUMORS OF THE PANCREAS [J].
BIELIGK, S ;
JAFFE, BM .
SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (05) :1025-+
[9]
TREATMENT OF INOPERABLE GLUCAGONOMA WITH THE LONG-ACTING SOMATOSTATIN ANALOG SMS 201-995 [J].
BODEN, G ;
RYAN, IG ;
EISENSCHMID, BL ;
SHELMET, JJ ;
OWEN, OE .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1686-1689
[10]
BODEN G, 1989, GASTROENTEROL CLIN N, V18, P831